Integrating personal values into primary care for Veterans with multimorbidity

将个人价值观融入患有多种疾病的退伍军人的初级保健中

基本信息

  • 批准号:
    10538185
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-01-01 至 2027-12-31
  • 项目状态:
    未结题

项目摘要

Background: Veterans with > 2 chronic conditions (multimorbidity) comprise almost 50% of patients in the Veterans Health Administration (VA). Primary care providers (PCPs) provide over 90% of outpatient VA care for the most complex, high-risk Veterans with multimorbidity. At present, these patients and their PCPs must juggle numerous healthcare and psychosocial needs with limited time and resources, both in clinic and in self- management at home. Patients and PCPs also make decisions about what care needs to prioritize without adequate guidance from clinical practice guidelines, many of which focus on single-disease processes. Patients and PCPs often disagree about what is most important; patients prioritize symptoms, while PCPs emphasize prognosis. Studies suggest that helping patients and PCPs communicate about what is most meaningful in life to patients (i.e., “personal values”) and align preferred health outcomes (i.e., “health priorities”) streamlines care, lowers treatment burden, and reduces unwanted interventions. To date, no study has clarified the circumstances in which personal values can guide health decisions or developed an approach linking personal values and actionable clinical care that helps navigate tensions between conflicting priorities. To address these gaps, this CDA will integrate a patient’s personal values into high-quality primary care by developing and testing an intervention (“Vet-Align”), a values-based approach to care for higher-risk Veterans with multimorbidity. Significance/Impact: This CDA advances VA and HSR&D priorities by improving patient-centric primary care and addressing what matters most to Veterans. This has long-term implications, including improving the specificity and personalization of VA quality metrics, advancing universal health outcomes, promoting patient engagement and adherence in care, and reducing waste and harm from unwanted or inappropriate care. Innovation: This CDA develops and tests a novel intervention using patient values and priorities to align primary care planning and delivery. This CDA will advance multimorbidity care and draws on novel methods including human-centered design (HCD) and multi-criteria decision analysis (MCDA), a participatory decision process. Specific Aims: 1) Understand how and when Veterans with multimorbidity connect values, health, and healthcare, to clarify the life and health circumstances where patient values directly influence PCP-patient care planning and self-management decisions; 2) Examine how VA ambulatory quality metrics align with and support patient priorities and values, to develop guidance for aligning disease-oriented quality metrics with patient- centered priorities of Veterans within a personal values-based care delivery model; 3) Refine and pilot test the acceptability and feasibility of Vet-Align, a values-based intervention for Veterans with multimorbidity, including tools and workflows for VA primary care to translate patient values into actionable clinical care plans. Methodology: Patients with > 2 chronic diseases at higher risk for adverse events are eligible for Aims 1 and 3. Aim 1 uses 25-30 semi-structured patient interviews, analyzed with content analysis. Aim 2 uses MCDA to combine healthcare expert perspectives and clinical evidence to rank outpatient VA quality metrics according to a patient’s preferred health priority. Building from findings and products from prior Aims, Aim 3a develops a novel, PCP-facing action-planning tool and workflows using HCD. Aim 3b pilot tests the tool in a clinical intervention (Vet-Align) for 30-36 patients and 15-20 PCPs. Vet-Align includes staff skills training and patient sessions with health coaches to elicit patient values, set health priorities, and personalize the action planning tool to send to PCPs. Feasibility and acceptability will be assessed from patient and staff perspectives. Next Steps/Implementation: The intervention developed in this CDA-2 will provide the foundation for a full randomized clinical trial evaluating clinical effectiveness through change in patient-centered outcomes and care quality, and testing implementation strategies for sustainment. Long term goals of this research trajectory are to strengthen the patient-centeredness and quality of VA primary care for Veterans with multimorbidity.
背景:退伍军人有> 2种慢性疾病(多发性硬化症), 退伍军人健康管理局(VA)。初级保健提供者(PCP)提供超过90%的门诊VA护理, 最复杂,最危险的退伍军人目前,这些患者和他们的PCP必须在 在时间和资源有限的情况下,无论是在诊所还是在自我治疗中, 在家管理。患者和PCP还可以决定哪些护理需要优先考虑, 从临床实践指南中得到充分的指导,其中许多指南侧重于单一疾病的治疗过程。患者 和PCP往往不同意什么是最重要的;患者优先考虑症状,而PCP强调 预后研究表明,帮助患者和PCP沟通生活中最有意义的事情 对于患者(即,"个人价值观")并调整优选的健康结果(即,"健康优先事项")简化了护理, 降低治疗负担,减少不必要的干预。迄今为止,没有任何研究澄清了这些情况。 个人价值观可以指导健康决策,或者开发了一种将个人价值观与 可操作的临床护理,有助于解决相互冲突的优先事项之间的紧张关系。为了弥补这些差距, CDA将通过开发和测试 干预("Vet-Align"),一种基于价值观的方法,用于照顾患有多发性硬化症的高风险退伍军人。 意义/影响:该CDA通过改善以患者为中心的初级保健,推进VA和HSR & D优先事项 和解决对退伍军人最重要的问题。这具有长期影响,包括改善 VA质量指标的特异性和个性化,促进全民健康结局,促进患者 参与和坚持护理,并减少不必要或不适当的护理造成的浪费和伤害。 创新:该CDA使用患者价值观和优先级开发和测试一种新的干预措施,以调整主要 护理规划和提供。该CDA将推进多患者护理,并借鉴新的方法,包括 以人为本的设计(HCD)和多标准决策分析(MCDA),一个参与式的决策过程。 具体目标:1)了解如何以及何时退伍军人与多morphology连接的价值观,健康, 医疗保健,以澄清患者价值观直接影响PCP患者护理的生活和健康情况 规划和自我管理决策; 2)检查VA门诊质量指标如何与 患者优先级和价值观,以制定指导方针,使疾病导向的质量指标与患者- 在基于个人价值观的护理提供模式中,以退伍军人为中心的优先事项; 3)完善和试点测试 Vet-Align的可接受性和可行性,Vet-Align是一种基于价值观的干预措施,适用于患有多种疾病的退伍军人,包括 用于退伍军人管理局初级保健的工具和工作流程,将患者价值观转化为可操作的临床护理计划。 方法学:患有> 2种慢性疾病且不良事件风险较高的患者符合目标1和3。 目标1使用25 - 30个半结构化的患者访谈,用内容分析法进行分析。目标2使用军事和民防资源, 联合收割机结合医疗保健专家的观点和临床证据,根据以下方面对门诊VA质量指标进行排名 病人的健康优先权目标3a以先前目标的调查结果和产品为基础, 新的、面向PCP的行动规划工具和使用HCD的工作流程。Aim 3b在临床中对该工具进行了初步测试 30 - 36名患者和15 - 20名PCP的干预(Vet-Align)。Vet-Align包括员工技能培训和患者 与健康教练举行会议,以了解患者的价值观,设定健康优先事项,并制定个性化的行动计划 发送给PCP的工具。将从患者和工作人员的角度评估可行性和可接受性。 后续步骤/实施:本CDA-2中制定的干预措施将为全面的 通过以患者为中心的结局和护理的变化评价临床有效性的随机临床试验 质量和测试维持的执行战略。本研究的长期目标是 加强以病人为中心和质量的VA初级保健的退伍军人与多mortim。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linnaea Schuttner其他文献

Linnaea Schuttner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了